Coreweave (CRWV) CEO says its new cloud product, Forge, will boost margins
A CEO guiding margins higher on a new product is a standard promotional pattern in the AI infrastructure space, where management commentary often substitutes for segment-level disclosure.
Coreweave (CRWV) CEO says its new cloud product, Forge, will boost margins
Google (GOOGL) introduces SynthID Bio
SNB Governing Board Member Tschudin says it is important that digital money types are set up so they do not limit the carrying out of the central bank's mandate
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
- Right now, Nvidia (NVDA) chip is the best from a client view.
Coreweave's economics hinge on GPU utilization and the spread between rental rates and hardware funding costs, so the operative question is whether Forge shifts that mix toward higher-margin managed services or simply re-badges existing capacity. The explicit nod to Nvidia reinforces the supplier-customer dynamic that has defined this cohort: the chipmaker's architecture remains the de facto standard, limiting differentiation at the silicon layer and concentrating pricing power upstream. Historically, margin claims from high-beta AI names have tended to fade on delivery unless accompanied by backlog conversion or a visible shift in the revenue mix toward software-like layers. Worth noting is whether the company provides a framework for measuring this uplift, as vague product-level promises in this space have often preceded volatility when the next print fails to validate the narrative.
Related headlines
- Google (GOOGL) introduces SynthID Bio21 min ago
- David Ellison is bulking up his executive team with a big poach: Ynon Kreiz, formerly of Mattel, is headed to the combined WBD - PSKY, reports Semafor citing sources23 min ago
- US Transportation Secretary Duffy says the FAA needs to accelerate certification of new aircraft47 min ago
- Eli Lilly's (LLY) EloraTZP delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetes1 hour ago
- US EQUITY OPEN: Indices open in the green post cooler-than-expected PCE as MU numbers await1 hour ago
- Nevada reports August casino gaming revenue of USD 1.27bln, +3.1% Y/Y, and Las Vegas strip revenue USD 684.1mln, +0.7% Y/Y1 hour ago
- The US FTC is reportedly ramping up probes of Anthropic, OpenAI and other frontier labs to uncover the potential dangers its technology poses to consumers and plans to give formal demands, NYP reports2 hours ago
- Caterpillar (CAT) intends to invest approximately USD 1bln in North Carolina to expand manufacturing capacity for products that support its growing Cat CompactSM business2 hours ago
- Synopsys (SNPS) and Amazon (AMZN) announce strategic, Multi-year IP agreement for Custom Silicon; Collaboration also extends to cloud and AI-powered engineering; agreement worth USD 1bln2 hours ago
- Coreweave (CRWV) to offer Nvidia (NVDA) Vera, the first CPI built for AI agents2 hours ago
- Merck's (MRK) tulisokibart met primary and key secondary endpoints in Phase 2b study in patients with moderate to severe hidradenitis suppurativa3 hours ago
- Mattel (MAT) names Roger Lynch as CEO3 hours ago
- Airbnb (ABNB) launches meal delivery service in select European cities3 hours ago
- US BROKER MOVES: TGT upgraded at HSBC; MRNA downgraded at Citi3 hours ago
- New Phase 3b data show Eli Lilly's (LLY) EBGLYSS (lebrikizumab-lbkz) delivered significant and rapid improvements in skin clearance, itch, pain, and patient satisfaction in people with moderate-to-severe hand dermatitis; primary endpoint met3 hours ago
- Hewlett Packard Enterprise (HPE) secures its first AMD (AMD) Helios order in USD 1.2bln deal with Vultr3 hours ago
- Norwegian Cruise Line (NCLH) expects Q3 2026 results to exceed guidance and reaffirms FY26 outlook3 hours ago
- Conagra Brands (CAG) Q1 2026 (USD): Adj. EPS 0.41 (exp. 0.28), revenue 2.6bln (exp. 2.59bln). 4 hours ago
- Cigna (CI) backs FY26 adj. EPS view 'at least' USD 30.45 (exp. 30.51) and consolidated adj. revenues about USD 280bln (exp. 286.76bln); medical care ratio seen between 83.7-84.7%; announces USD 3bln multi-year modernization and productivity initiative4 hours ago
- Hormel Foods (HRL) agrees to buy Brakebush for USD 1.055bln in cash4 hours ago
The whole workspace, free to try.
Try it free